The peroxisomal oxidation of the long chain fatty acid palmitate (C16:0) and the very long chain fatty acids lignocerate (C24:0) and cerotate (C26:0) was studied in freshly prepared homogenates of cultured skin fibroblasts from control individuals and patients with peroxisomal disorders. The peroxisomal oxidation of the fatty acids is almost completely dependent on the addition of ATP, coenzyme A (CoA), Mg2+ and NAD'.
Introduction
Although peroxisomes were long believed to have only a minor function in mammalian metabolism, it has become clear in recent years that these organelles play an important role in a number of metabolic pathways including fatty acid ,B-oxidation, ether-phospholipid biosynthesis and bile acid biosynthesis (for reviews see [1] [2] [3] [4] . The importance ofperoxisomes in man can be gauged from the existence of a group of genetic diseases caused by an impairment in one or more peroxisomal functions (5) (6) (7) (8) . Goldfischer and co-workers (9) were the first to observe that morphologically distinguishable peroxisomes are absent in liver and kidney tubules from patients with the cerebro-hepato-renal (Zellweger) syndrome, the prototype of this newly recognized group of peroxisomal disorders.
In 1976 Lazarow and de Duve (10) reported that mammalian peroxisomes are capable of oxidizing fatty acyl-coenzyme A (CoA)' esters. Subsequent studies revealed that fatty acylCoA p-oxidation in peroxisomes occurs via a true p3-oxidation system involving sequential steps of oxidation, hydration, dehydrogenation, and thiolytic cleavage (1 1). Rather than being a duplication of the mitochondrial 3-oxidation system, mammalian peroxisomes seem specially equipped to catalyze the chain-shortening of monounsaturated long chain fatty acids (12) and saturated very long chain fatty acids ( 13) .
Before fatty acids can undergo further metabolism, activation to the corresponding fatty acyl-CoA esters must occur ( 14) . Several acyl-CoA synthetases are known to be present in mammalian cells (14, 15) including long chain acyl-CoA synthetase (acid:CoA ligase (AMP-forming), EC 6.2.1.3; also known as palmitoyl-CoA synthetase), which has been found to be localized in mitochondria and microsomes (for reviews see 14, 15) as well as in peroxisomes (16) (17) (18) (19) . Evidence has recently been brought forward (20) (25) were measured according to published procedures.
Patients. The patients studied in this paper were selected on the basis of established diagnoses. The Zellweger patients studied have been described elsewhere (28, 29). The infantile Refsum patients studied represent the three cases described by Saudubray and co-workers (30, 31) . The neonatal adrenoleukodystrophy patients have also been described before (32, 33) . The X-linked adrenoleukodystrophy patients showed the typical clinical and biochemical features described in the literature (34, 35) . There was an accumulation of very long chain fatty acids, measured gaschromatographically as described by Moser and co-workers (36, 37) and expressed as C26:0/C22:0 ratio in fibroblasts from the patients (see below). Table I shows the cofactor requirements for the peroxisomal fl-oxidation of fatty acids in postnuclear supernatants of cultured skin fibroblasts. KCN was present to inhibit the mitochondrial fl-oxidation system (38, 39) . In fibroblasts, as in rat liver homogenates, the peroxisomal f-oxidation of palmitate (39), lignocerate (21), and cerotate is completely dependent upon the addition of ATP, coenzyme A, MgCl2 and NAD+ (40) . Omission of FAD had very little effect with either substrate.
Results
We have previously shown that in rat liver homogenates the peroxisomal fl-oxidation of palmitate (C16:0) and lignocerate (C24:0) show different dependencies upon the concentration of ATP, coenzyme A, Mg2' and NAD+ (21). Fig. 1 shows that this is also the case for human fibroblasts. As with rat liver homogenates this was especially apparent in the case of ATP; the concentration required to give half-maximal rates of (-oxidation was -10 mM in the case of lignocerate and 0.12 mM in the case of palmitate. Evidence for the presence of different fatty acid activating enzyme systems for palmitate and lignocerate in rat liver homogenates has recently been obtained by competition experiments (21). Similar results have now been obtained with fibroblast homogenates. Fig. 2 shows that the activation of palmitic acid to palmitoyl-CoA as measured in homogenates of cultured skin fibroblasts is not affected by addition of lignoceric acid or cerotic acid (C26:0), whereas the activation of lignoceric acid and cerotic acid to lignoceroyl-CoA and cerotoylCoA, respectively, is not affected by addition of palmitic acid. On the other hand the activation of lignoceric acid is inhibited by cerotic acid and vice versa. Thus, as in rat liver, fibroblast homogenates contain at least two fatty acid activating enzyme systems, one able to activate palmitate and the other able to activate both lignocerate and cerotate. Table II shows that there was an accumulation of very long chain fatty acids, as indicated by an elevated C26:0/C22:0 ratio, in fibroblasts from patients with the different peroxisomal disorders. Table II shows further that fibroblasts from patients with the Zellweger syndrome, infantile Refsum disease and neonatal adrenoleukodystrophy, genetic diseases characterized by a deficiency of peroxisomes (9, 32, 41-44), are deficient in the ability to oxidize the very long chain fatty acids lignoceric acid and cerotic acid. Furthermore, the peroxisomal (3-oxidation of palmitate, too, was found to be deficient in Zellweger fibroblasts.
Fibroblasts from patients with the X-linked form of adrenoleukodystrophy are able to 3-oxidize palmitic acid at near normal rates but not lignoceric acid and cerotic acid (Table II) . These findings, together with the observation by Hashmi and co-workers (22) and ourselves (unpublished results) that lignoceroyl-CoA and palmitoyl-CoA are oxidized at normal rates in fibroblasts from patients with X-linked adrenoleukodystrophy, suggest that the peroxisomal enzyme responsible for the activation of lignoceric acid and cerotic acid is deficient in X-linked adrenoleukodystrophy. Measurement of very long chain fatty acyl-CoA synthetase activity with cerotic acid as substrate indicates that there is a small (-25%) but significant (P < 0.02) deficiency of this activity in fibroblasts from patients with X-linked adrenoleukodystrophy (Table III) . This partial deficiency suggests that there is more than one enzyme able to catalyze the activation of very long chain fatty acids, and that only one of these enzymes is deficient in X-linked adrenoleukodystrophy. A partial deficiency is also found in the Zellweger syndrome (Table III; see Discussion) .
We have therefore investigated the subcellular distribution of this enzyme activity. Since adequate methods to separate the different subcellular organelles present in cultured skin fibroblasts are not available at present, we have carried out fractionation experiments with rat liver using the procedure described by Wattiaux and co-workers (25) . Fig. 3 shows the results of a typical experiment. A good separation between peroxisomes, mitochondria, and microsomes was obtained as indicated by the marker enzymes catalase, glutamate dehydrogenase and NADPH-cytochrome c reductase, respectively. The results of Fig. 3 show that palmitoyl-CoA synthetase is present in peroxisomes, mitochondria and microsomes, in agreement with data from a number of authors (16) (17) (18) (19) . In contrast, however, very long chain fatty acyl-CoA synthetase showed a bimodal distribution of activity; the enzyme is present only in peroxisomes and microsomes and not in mitochondria. This conclusion was further substantiated by additional Metrizamide gradient centrifugation experiments, in which the mitochondrial (M) and microsomal (Mc) fractions rather than the light mitochondrial (ML) fraction were used (23) .
Discussion
In Zellweger syndrome the deficient peroxisomal oxidation of palmitate, lignocerate and cerotate can be explained by the deficiency of the three peroxisomal fl-oxidation enzyme proteins as shown in liver by immunoblotting (45-47). Studies in cultured skin fibroblasts have shown that peroxisomal fl-oxidation enzyme proteins are synthesized normally in Zellweger syndrome but are degraded rapidly due to the absence of peroxisomes (48) . The same applies to infantile Refsum disease and neonatal adrenoleukodystrophy in which peroxisomes have also been shown to be strongly deficient in liver (32, (41) (42) (43) (44) and cultured fibroblasts (33, 49) .
Immunoblotting experiments carried out with liver from X-linked adrenoleukodystrophy patients revealed that all three peroxisomal :-oxidation enzyme proteins were present in normal amounts (results not shown). These results do not exclude the possibility that one of the three proteins is catalytically inactive. However, the finding that the peroxisomal oxidation of palmitate is normal in X-linked adrenoleukodystrophy fibroblasts (13, 22; and Table II) and liver (44) shows that the defect cannot be at the level of acyl-CoA oxidase, 
